Conning Inc. decreased its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 24.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,895 shares of the pharmacy operator’s stock after selling 5,262 shares during the period. Conning Inc.’s holdings in Walgreens Boots Alliance were worth $1,006,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the company. Horan Capital Advisors LLC. bought a new position in shares of Walgreens Boots Alliance in the 1st quarter valued at about $25,000. Massey Quick Simon & CO. LLC bought a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at about $27,000. Murphy Pohlad Asset Management LLC bought a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at about $29,000. Cornerstone Advisors Inc. lifted its holdings in shares of Walgreens Boots Alliance by 102.4% in the 3rd quarter. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 214 shares during the last quarter. Finally, PRW Wealth Management LLC bought a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at about $34,000. Hedge funds and other institutional investors own 65.05% of the company’s stock.

Shares of NASDAQ WBA opened at $54.10 on Tuesday. The company has a quick ratio of 0.38, a current ratio of 0.78 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $49.95 billion, a price-to-earnings ratio of 8.99, a PEG ratio of 1.11 and a beta of 0.86. Walgreens Boots Alliance Inc has a 1 year low of $53.32 and a 1 year high of $86.31.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.70 by ($0.06). The firm had revenue of $34.53 billion during the quarter, compared to the consensus estimate of $34.57 billion. Walgreens Boots Alliance had a return on equity of 22.00% and a net margin of 3.77%. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.73 EPS. On average, sell-side analysts predict that Walgreens Boots Alliance Inc will post 5.99 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Monday, May 20th will be paid a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 3.25%. The ex-dividend date is Friday, May 17th. Walgreens Boots Alliance’s payout ratio is currently 29.24%.

In related news, COO Ornella Barra purchased 18,000 shares of the firm’s stock in a transaction dated Wednesday, April 3rd. The stock was purchased at an average price of $54.56 per share, with a total value of $982,080.00. Following the completion of the purchase, the chief operating officer now owns 26,425 shares of the company’s stock, valued at approximately $1,441,748. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 15.73% of the company’s stock.

WBA has been the subject of a number of analyst reports. Citigroup lowered their price target on shares of Walgreens Boots Alliance from $76.00 to $60.00 and set a “neutral” rating for the company in a report on Wednesday, April 3rd. UBS Group initiated coverage on shares of Walgreens Boots Alliance in a report on Thursday, January 17th. They issued a “sell” rating and a $70.00 price target for the company. ValuEngine downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Friday, March 1st. Morgan Stanley lowered their price target on shares of Walgreens Boots Alliance from $77.00 to $67.00 and set an “equal weight” rating for the company in a report on Tuesday, March 5th. Finally, Bank of America reaffirmed an “underperform” rating and issued a $62.00 price target (down previously from $69.00) on shares of Walgreens Boots Alliance in a report on Friday, March 8th. Five research analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have issued a buy rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average price target of $68.00.

ILLEGAL ACTIVITY NOTICE: This article was originally published by Watch List News and is the property of of Watch List News. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-shares-sold-by-conning-inc/2981954.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Story: Producer Price Index (PPI)

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.